- -

Immuno-Electrophysiological Mechanisms of Functional Electrical Connections Between Recipient and Donor Heart in Patients With Orthotopic Heart Transplantation Presenting With Atrial Arrhythmias

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Immuno-Electrophysiological Mechanisms of Functional Electrical Connections Between Recipient and Donor Heart in Patients With Orthotopic Heart Transplantation Presenting With Atrial Arrhythmias

Mostrar el registro sencillo del ítem

Ficheros en el ítem

dc.contributor.author Herweg, Bengt es_ES
dc.contributor.author Nellaiyappan, Madhan es_ES
dc.contributor.author Welter-Frost, Allan M. es_ES
dc.contributor.author Tran, Thanh es_ES
dc.contributor.author Mabry, George es_ES
dc.contributor.author Weston, Kathryn es_ES
dc.contributor.author Tobón, Catalina es_ES
dc.contributor.author Saiz Rodríguez, Francisco Javier es_ES
dc.contributor.author Noujaim, Sami es_ES
dc.contributor.author Weston, Mark W. es_ES
dc.date.accessioned 2022-05-10T18:06:18Z
dc.date.available 2022-05-10T18:06:18Z
dc.date.issued 2021-04 es_ES
dc.identifier.issn 1941-3149 es_ES
dc.identifier.uri http://hdl.handle.net/10251/182475
dc.description.abstract [EN] BACKGROUND: The formation of recipient-to donor atrio-atrial connections (AAC) in patients after orthotopic heart transplantation (OHT) is poorly understood. We sought to investigate the mechanisms of atrial tachyarrhythmias after OHT, the role of AACs, and their relationship to the immunologic match. METHODS: In a large series of OHT patients, we performed a retrospective review of 42 patients who underwent catheter ablation for atrial arrhythmias. A realistic 3-dimensional computer model of human atria was used to study AAC conductivity. RESULTS: Patient age was 55 +/- 15 years (71% male). Biatrial anastomosis was present in 24/42 patients (57%). An AAC was found in 9/42 patients (21%, right-sided in 5 patients with biatrial anastomosis, left-sided in 4 patients). The AAC became apparent at the time of the electrophysiology study 10.1 +/- 7.6 years after OHT (range, 0.3-22.2 years). Donor-specific antibodies were present in no patient with AAC but were present in 69% of patients without AAC, P=0.002. In all patients with AAC, a recipient atrial tachycardia propagated via AAC to the donor atrium (4 patients presented with atrial fibrillation). Simulations showed AAC conduction requires an isthmus of >= 2 mm and is cycle length and location dependent. Patients without AAC (n=13) frequently presented with donor atrial arrhythmias, in 77% cavo-tricuspid isthmus flutter was ablated. The procedural success was high, although, 12 patients (29%) required reablation. CONCLUSIONS: AACs are found in 21% of OHT patients with atrial tachyarrhythmias and can manifest very early after OHT. Immune privilege characterized by the absence of donor-specific antibodies may facilitate AAC formation. Propagation across an AAC is width, cycle length, and location dependent. Patients with AAC present with focal atrial tachycardias or atrial fibrillation originating from the recipient atria; patients without most frequently present with cavo-tricuspid isthmus dependent atrial flutter. While multiple arrhythmias frequently require reablation, ablative therapy is highly effective. es_ES
dc.description.sponsorship This study was supported in part by National Institutes of Health grants R21HL138064, and R01HL129136 to Dr Noujaim. This work was partially supported by the Direccion General de Politica Cientifica de la Generalitat Valenciana (PROMETEU2020/043). es_ES
dc.language Inglés es_ES
dc.publisher Ovid Technologies Wolters Kluwer -American Heart Association es_ES
dc.relation GENERALITAT VALENCIANA//PROMETEO%2F2012%2F030//MEJORA EN LA PREVENCION Y TRATAMIENTO DE PATOLOGIAS CARDIACAS A TRAVES DE LA MODELIZACION MULTI-ESCALA Y LA SIMULACION COMPUTACIONAL (DIGITAL HEART)/ es_ES
dc.relation.ispartof Circulation Arrhythmia and Electrophysiology es_ES
dc.rights Reserva de todos los derechos es_ES
dc.subject Atrial fibrillation es_ES
dc.subject Catheter ablation es_ES
dc.subject Electrophysiology es_ES
dc.subject Heart transplantation es_ES
dc.subject Tachycardia es_ES
dc.subject.classification TECNOLOGIA ELECTRONICA es_ES
dc.title Immuno-Electrophysiological Mechanisms of Functional Electrical Connections Between Recipient and Donor Heart in Patients With Orthotopic Heart Transplantation Presenting With Atrial Arrhythmias es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.1161/CIRCEP.120.008751 es_ES
dc.relation.projectID info:eu-repo/grantAgreement/NIH//R21HL138064/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/NIH//R01HL129136/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/GVA//PROMETEO%2F2020%2F043//MODELOS IN-SILICO MULTI-FISICOS Y MULTI-ESCALA DEL CORAZON PARA EL DESARROLLO DE NUEVOS METODOS DE PREVENCION, DIAGNOSTICO Y TRATAMIENTO EN MEDICINA PERSONALIZADA (HEART IN-SILICO MODELS)/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/GENERALITAT VALENCIANA es_ES
dc.rights.accessRights Abierto es_ES
dc.contributor.affiliation Universitat Politècnica de València. Departamento de Ingeniería Electrónica - Departament d'Enginyeria Electrònica es_ES
dc.description.bibliographicCitation Herweg, B.; Nellaiyappan, M.; Welter-Frost, AM.; Tran, T.; Mabry, G.; Weston, K.; Tobón, C.... (2021). Immuno-Electrophysiological Mechanisms of Functional Electrical Connections Between Recipient and Donor Heart in Patients With Orthotopic Heart Transplantation Presenting With Atrial Arrhythmias. Circulation Arrhythmia and Electrophysiology. 14(4):412-423. https://doi.org/10.1161/CIRCEP.120.008751 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion https://doi.org/10.1161/CIRCEP.120.008751 es_ES
dc.description.upvformatpinicio 412 es_ES
dc.description.upvformatpfin 423 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 14 es_ES
dc.description.issue 4 es_ES
dc.identifier.pmid 33724864 es_ES
dc.identifier.pmcid PMC8081261 es_ES
dc.relation.pasarela S\462103 es_ES
dc.contributor.funder Generalitat Valenciana es_ES
dc.contributor.funder National Institutes of Health, EEUU es_ES
dc.subject.ods 03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edades es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem